Reveal LINQ vs AHI System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (Reveal LINQ) is an implantable device designed for long-term diagnostic monitoring of cardiac arrhythmias using AI-powered ECG analysis. In contrast, Tool B (AHI System) is a software-only solution that provides real-time predictive analytics for hemodynamic instability in acute care settings, also utilizing continuous ECG signals. While both leverage AI and ECG data for patient insights, their distinct clinical focus areas and deployment models make them suitable for different stages of patient care and different medical specialties.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Medtronic Reveal LINQ is designed for the continuous recording of ECG to detect and diagnose cardiac arrhythmias, such as atrial fibrillation, cryptogenic stroke, and unexplained syncope, over an extended period of up to three years. Fifth Eye's AHI System, conversely, provides real-time predictive analytics for hemodynamic instability, aiming to detect patient deterioration hours before changes in vital signs, primarily for critical care and emergency settings.
The Medtronic Reveal LINQ continuously records its own subcutaneous ECG for up to three years using the implanted monitor. The AHI System utilizes continuous Lead II ECG signals from existing patient monitoring platforms within the hospital environment.
Reveal LINQ is primarily relevant for Cardiology and Neurology, focusing on patients with infrequent symptoms requiring long-term cardiac monitoring for arrhythmia detection, including those with cryptogenic stroke or unexplained syncope. The AHI System is designed for Critical Care, Emergency Medicine, and Hospital Medicine, providing early warning for hemodynamic instability in adult in-hospital patients receiving continuous physiological monitoring.
Reveal LINQ uses AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation and pause, and to significantly reduce false alerts, thereby improving information accuracy and reducing clinician review burden. The AHI System employs AI-powered predictive analytics to interpret ECG waveform signal variations, detecting signs of hemodynamic instability hours before vital signs change, which enhances clinical decision-making and helps optimize hospital resources.
The Medtronic Reveal LINQ provides continuous ECG monitoring for up to three years. The AHI System offers continuous monitoring and trending as long as it is integrated with existing patient monitoring platforms within the hospital setting.